On September 4, 2020 Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology, reported that Pearl Huang, Ph.D., President and Chief Executive Officer, will present a company overview as part of Wells Fargo’s 2020 Virtual Healthcare Conference on Wednesday, September 9, 2020 at 3:20 p.m. E.T (Press release, Cygnal Therapeutics, SEP 4, 2020, View Source [SID1234564512]). The event will be held virtually. Registration is available for clients through Wells Fargo.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!